Pilin Wang

804 total citations
30 papers, 632 citations indexed

About

Pilin Wang is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Pilin Wang has authored 30 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Pilin Wang's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and HER2/EGFR in Cancer Research (4 papers). Pilin Wang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and HER2/EGFR in Cancer Research (4 papers). Pilin Wang collaborates with scholars based in China, Japan and United States. Pilin Wang's co-authors include Ting Xu, Aiwu Zhou, Hudie Wei, Haiyan Cai, Siyuan Cheng, Sijuan Zou, Dan Li, Xiaohua Zhu, Yali Su and June Liu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Pilin Wang

30 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pilin Wang China 11 335 214 196 164 46 30 632
Kristina G. Flores United States 15 156 0.5× 39 0.2× 306 1.6× 127 0.8× 59 1.3× 21 794
Myra E. van Linde Netherlands 14 188 0.6× 107 0.5× 219 1.1× 70 0.4× 157 3.4× 34 719
Patricia Dill Switzerland 14 97 0.3× 59 0.3× 238 1.2× 144 0.9× 27 0.6× 29 728
Bruce W. Ennis United States 16 398 1.2× 122 0.6× 447 2.3× 69 0.4× 96 2.1× 23 1.0k
Anne Caron France 9 196 0.6× 123 0.6× 136 0.7× 53 0.3× 17 0.4× 15 385
Jennifer J. Tsai United States 11 211 0.6× 30 0.1× 245 1.3× 447 2.7× 41 0.9× 22 878
De‐Yan Hou United States 8 249 0.7× 121 0.6× 183 0.9× 468 2.9× 82 1.8× 15 876
Noam Asna Israel 10 144 0.4× 45 0.2× 196 1.0× 51 0.3× 103 2.2× 31 557
Ravi Ramjeesingh Canada 13 299 0.9× 30 0.1× 274 1.4× 76 0.5× 79 1.7× 48 649

Countries citing papers authored by Pilin Wang

Since Specialization
Citations

This map shows the geographic impact of Pilin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilin Wang more than expected).

Fields of papers citing papers by Pilin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilin Wang. The network helps show where Pilin Wang may publish in the future.

Co-authorship network of co-authors of Pilin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Pilin Wang. A scholar is included among the top collaborators of Pilin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilin Wang. Pilin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Ling, Peipei Ding, Yanrong Dong, et al.. (2024). CG001, a C3b-targeted complement inhibitor, blocks 3 complement pathways: development and preclinical evaluation. Blood Advances. 8(15). 4181–4193. 3 indexed citations
3.
Ren, Lehao, et al.. (2024). Ki-67 Change in Anthracyline-containing Neoadjuvant Chemotherapy Response in Breast Cancer. Current Medical Science. 44(1). 156–167. 3 indexed citations
4.
Wang, Feng, et al.. (2023). Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods. Translational Cancer Research. 12(5). 1112–1127. 3 indexed citations
5.
6.
Wang, Lin, et al.. (2020). The Identification of Gene Expression Profiles Associated with Granulomatous Mastitis. Breast Care. 16(4). 319–327. 8 indexed citations
7.
Liu, June, et al.. (2019). Supporting her as the situation changes: A qualitative study of spousal support strategies for patients with breast cancer in China. European Journal of Cancer Care. 29(1). e13176–e13176. 18 indexed citations
8.
9.
Li, Dan, et al.. (2018). Immuno-PET Imaging of 89Zr Labeled Anti-PD-L1 Domain Antibody. Molecular Pharmaceutics. 15(4). 1674–1681. 98 indexed citations
10.
Zhang, Fei, Hudie Wei, Xiaoxiao Wang, et al.. (2017). Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade. Cell Discovery. 3(1). 17004–17004. 167 indexed citations
11.
Zhao, Meng, Wang Jia, Wen G. Jiang, et al.. (2016). ADAM29 Expression in Human Breast Cancer and its Effects on Breast Cancer Cells In Vitro.. ORCA Online Research @Cardiff (Cardiff University). 36(3). 1251–8. 9 indexed citations
12.
Zhang, Yinli, Shu‐Yan Ji, Xiaoman Liu, et al.. (2015). Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit. Human Reproduction. 31(1). 169–182. 20 indexed citations
13.
Sun, Xu, et al.. (2014). Ileal interposition reduces blood glucose levels and decreases insulin resistance in a type 2 diabetes mellitus animal model by up-regulating glucagon-like peptide-1 and its receptor.. PubMed. 7(7). 4136–42. 8 indexed citations
14.
Sun, Xu, et al.. (2013). Ileal interposition surgery-induced improvement of hyperglycemia and insulin resistance in Goto-Kakizaki rats by upregulation of TCF7L2 expression. Experimental and Therapeutic Medicine. 5(5). 1511–1515. 5 indexed citations
15.
Chen, Shudong, et al.. (2012). Knockdown of Radixin by RNA interference Suppresses the Growth of Human Pancreatic Cancer Cells in Vitro and in Vivo. Asian Pacific Journal of Cancer Prevention. 13(3). 753–759. 18 indexed citations
16.
Wang, Pilin, Tetsuhiro Niidome, Toshiaki Kume, et al.. (2011). Functional and molecular interactions between Rac1 and FE65. Neuroreport. 22(14). 716–720. 5 indexed citations
17.
Song, Mao‐Min, et al.. (2009). Suppression of matrix metalloproteinase-2 via RNA interference inhibits pancreatic carcinoma cell invasiveness and adhesion. World Journal of Gastroenterology. 15(9). 1072–1072. 23 indexed citations
18.
Niidome, Tetsuhiro, Masaru Kato, Pilin Wang, et al.. (2009). Non-fibrillar amyloid-β peptide reduces NMDA-induced neurotoxicity, but not AMPA-induced neurotoxicity. Biochemical and Biophysical Research Communications. 386(4). 734–738. 5 indexed citations
19.
Wang, Pilin, Tetsuhiro Niidome, Akinori Akaike, Takeshi Kihara, & Hachiro Sugimoto. (2009). Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene. Journal of Neuroscience Research. 87(9). 2105–2114. 47 indexed citations
20.
Abe, Shunnosuke, Pilin Wang, Fuminori Takahashi, & Eiji Sasaki. (2005). Structural Analysis of cDNAs Coding for 4SNc-Tudor Domain Protein from Fish and Their Expression in Yellowtail Organs. Marine Biotechnology. 7(6). 677–686. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristina G. Flores Breakdown of academic impact, for papers by Myra E. van Linde Breakdown of academic impact, for papers by Patricia Dill Breakdown of academic impact, for papers by Bruce W. Ennis Breakdown of academic impact, for papers by Anne Caron Breakdown of academic impact, for papers by Jennifer J. Tsai Breakdown of academic impact, for papers by De‐Yan Hou Breakdown of academic impact, for papers by Noam Asna Breakdown of academic impact, for papers by Ravi Ramjeesingh
Rankless by CCL
2026